Uncategorized

University of Calgary researchers analyze Sosido data to reveal scientific publication trends in the Canadian College of Physicists in Medicine: Is research activity by clinical medical physicists in decline?

Researchers from the University of Calgary analyzed Sosido publication data over a 3-year period to reveal trends in academic output for CCPM-certified medical physicists.

They found that earlier-career medical physicists are publishing less than their more experienced colleagues. Do medical physicists increase academic output over the course of their career? Or is the newer generation of medical physicists simply publishing less?

Read the full article: Quirk S, Thind K, Myer T, Roumeliotis M. Scientific Publication Trends in the Canadian College of Physicists in Medicine. InterACTIONS. 2019 Oct; 65(4): 20-22. [download full text]

 

Sosido welcomes the members of the Statistics & Methodology Applied Rheumatology Training (SMART) community

This week we welcome the members of the Statistics & Methodology Applied Rheumatology Training (SMART) community to Sosido, pleased to support SMART’s goals to improve the interpretation and clinical application of research in rheumatology through discussion and collaboration.  Read more about SMART.

The Council for Continuing Pharmaceutical Education joins Sosido

The Council for Continuing Pharmaceutical Education (CCPE) is an unbiased not-for-profit that provides continuing professional development for healthcare industry professionals. As an outcome of the BenchSmart Series of studies examining the state of Pharma and its functions in Canada (www.benchsmart.ca), CCPE has launched several communities on Sosido include nationally-focused CCPE Canada, as well as specialty communities in Learning & Development, Digital Innovation, Medical Affairs, and Continuing Health Education. More about CCPE.

Welcome CCPE members!

The International Society of Oncology Pharmacy Practitioners (ISOPP) joins Sosido

The International Society of Oncology Pharmacy Practitioners (ISOPP) is a group of oncology pharmacy experts from more than 30 countries, focussed on advancing oncology pharmacy care for patients around the world, through leading edge oncology knowledge, best practices and essential networks. Read more about ISOPP

Welcome ISOPP members! If you’d like more information about how Sosido works, see our slide tour.

 

 

Would you like Sosido to feature the work of YOUR research group? Try it free in 2019.

Would you like to:

  • Raise the profile of the work of the researchers in your hospital, university, association or research network?
  • Learn about your colleagues’ papers as soon as they’re released?
  • Make it easy for your staff track the publications of team members, and keep CVs up to date?
  • Receive bibliometrics reports on the research output of your group?
  • All without any work for you, your staff, or your team members?

For information about a 6-month free trial of Sosido for your research group, contact tanis@sosido.com.

Sosido is an online network for healthcare professionals to share published research and clinical knowledge, connecting members within research groups, and across silos of specialty and region. Sosido is a global, multidisciplinary network, with over 35 groups and 18,000 clinicians and researchers participating from around the world. More about Sosido.

Happy holidays from all of us at Sosido!

 

 

 

 

 

 

 

 

We wish you peace, health and happiness this holiday season.

Sosido’s Privacy Policy has been updated

We’ve updated our Privacy Policy for the EU’s new General Data Protection Regulation (GDPR). See our revised policy here: http://blog.sosido.com/about/privacy-policy

Sosido nominated as a finalist for the 2018 Australian pharma awards.

From Cancer Nurses Society of Australia Media Release (Sydney, August 16 2018) — CNSA initiative recognised by Industry awards body — The CNSA-Sosido platform, a CNSA initiative supported by Roche Australia, has been nominated as a finalist at this year’s PRIME Awards.

These awards are considered a benchmark for recognising excellence in marketing, education and support initiatives across the Australian pharmaceutical and healthcare industries.

The ongoing initiative is a collaboration between the Cancer Nurses Society of Australia Ltd (CNSA), Sosido (the developers of the platform), Roche Australia (provision of sponsorship grant to develop and run the platform), and Swipe Health (coordination between all stakeholders to deliver the initiative).

Sosido provides an effective way for CNSA to communicate important announcements and keep members updated with the latest research impacting their practice, whilst fostering a community where members can crowdsource information, discuss trending topics and network with peers.

An impressive 1,530 CNSA members and followers are currently on the Sosido platform, and engagement has surpassed expectations. This is highlighted by the Q&A forum, which has seen almost 200 posts in the past year alone, generating helpful and insightful discussion amongst hundreds of members.

With the challenge of Australia’s geography being so spread out, the CNSA platform has found a way to bring their vast community of members closer together.

“We’ve received great feedback from our members regarding the Sosido platform” said Sonja Cronjé, Chief Executive Officer of CNSA. “We’d particularly like to thank Roche Australia for their support to help make this happen for our community of cancer nurses”.

The award winners will be announced in Sydney on 20 September.

For more information about CNSA see www.cnsa.org.au

For more information about Sosido see blog.sosido.com

Saying goodbye to Dr. Messner

It was with great sadness that we learned of the passing of Dr. Hans Messner on July 24, 2018. Dr. Messner left the world an immeasurably better place – through his vast accomplishments in the science of stem cell transplantation, his leadership in the blood cancer community, his input on government policy, and perhaps most of all, his impact on the lives of his patients and their families. Those of us who were lucky enough to work with him through the years were inspired and changed, by his warmth, energy, persistence, humility and vision. You would happily set your alarm for 5 am to lend him a hand.
I’m one of those people he left more inspired than he found me. Thank you and goodbye Hans. We will miss you.
— Tanis Steward and the Sosido Team

6th International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma, Sep 26-29 2018, Rotterdam, The Netherlands

The 6th International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma will be held September 26-29 2018 in Rotterdam, The Netherlands. This symposium is designed to present the latest scientific and clinical advances in childhood, adolescent, and young adult NHL, NHL biopathology, NHL genomics, stem cell transplantation, and immunobiology. The educational content of this conference will be relevant for Medical and Pediatric Oncologists, Stem and Immune Cell Transplantation Investigators, Basic Scientists, Physicians-in-Training (Fellows/Residents/Post Docs), Oncology Nurses and other associated allied health professionals. The conference will again feature internationally-recognized speakers from a multidisciplinary, diverse group comprised of basic scientists, translational biologists and clinical investigators. The conference includes formal didactic presentations, informal discussion panels, oral abstract presentations, poster discussions and poster presentations.

Click here to view the program